Jeremy Adler, MD

Jeremy Adler, MD, MSc

Specialty: Pediatric Gastroenterology, Pediatrics
Title: Clinical Professor
5/5
See All Ratings

To request an appointment call

734-763-9650
Jeremy Adler, MD, MSc
Pediatric Gastroenterology
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview
  • Links
  • Manage Your Profile

  • Areas of Practice

    Dr. Adler's clinical interests include childhood inflammatory bowel disease, including Crohn's disease and ulcerative colitis, improving disease outcomes, preventing complications, and successful transition from pediatrics to adulthood.

    Locations

    • Pediatric Gastroenterology Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 8 Reception B
      Ann Arbor, MI 48109-4259
      Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training

    University of South Florida College of Medicine, 1994

    Residency

    Boston Medical Center, Pediatrics, 1997

    Fellowships

    University of Michigan Health System, Pediatric Gastroenterology, 2008

    Board Certifications

    Pediatric Gastroenterology

    Professional Organizations

    American Gastroenterology Association
    Crohn's & Colitis Foundation
    European Crohn’s and Colitis Organisation
    North American Society for Pediatric Gastroenterology & Nutrition

    Research Overview

    Dr. Adler's research interests include improving long-term outcomes for children with Crohn's disease and ulcerative colitis. He focuses on preventing disease-related and treatment-related complications. He also works on improving strategies for targeting medical therapies to the needs of the individual.

    Links

    Child Health Evaluation and Research Center

    Featured News & Stories

    shot in arm patient rolled up sleeve
    Health Lab

    Why anti-TNF drugs don’t work for some kids with Crohn's disease

    Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 
    syringes three in a row with one with a shot going into it on a light teal background
    Health Lab

    TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies

    Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data.